Evidence map›Paper›PMID 42090046›Full record

ArticleJournal of artificial organs : the official journal of the Japanese Society for Artificial Organs2026

Oxygenator salvage with low-dose thrombolysis. Case report.

Rodrigo Díaz, Dafna García, Catalina Alvarado-Neves, Carmen Gloria Karlezi, Javier Gárate

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rodrigo DíazCardiovascular Critical Care Unit, ECMO Program Director, Clinica RedSalud Santiago, Avenida Bernardo O´Higgins 4850, Santiago, Chile. rodrigoa.diaz@redsalud.cl.ORCID http://orcid.org/0000-0001-8046-2229
Dafna GarcíaCardiovascular Center, Clinica RedSalud Santiago, Santiago, Chile.
Catalina Alvarado-NevesCardiovascular Center, Clinica RedSalud Santiago, Santiago, Chile.
Carmen Gloria KarleziCardiovascular Center, Clinica RedSalud Santiago, Santiago, Chile.
Javier GárateCardiovascular Center, Clinica RedSalud Santiago, Santiago, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Membrane oxygenator exchange can be a frequent requirement during extracorporeal membrane oxygenation (ECMO). In low-income health systems, the scarcity and cost of disposables pose significant challenges to timely exchanges. We describe a 48-year-old woman placed on veno-venous ECMO for refractory hypoxemic respiratory failure secondary to pneumonia. Within 30 min, the oxygenator developed thrombosis, characterized by a transmembrane pressure gradient of 229 mmHg. A total of 10 mg of recombinant tissue plasminogen activator (rt-PA) was administered through the premembrane port. Sixty minutes after infusion, the gradient decreased to 116 mmHg, with subsequent improvement in oxygenation. No bleeding occurred. The patient was successfully weaned from ECMO and discharged from the ICU without complications. Low-dose rtPA instillation into a failing oxygenator can postpone exchange and represents a viable salvage strategy for resource-limited ECMO programs.

Indexed as

Extracorporeal Membrane OxygenationFibrinolytic AgentsOxygenators, MembraneRespiratory InsufficiencySalvage TherapyThrombolytic TherapyThrombosisTissue Plasminogen ActivatorFemaleHumansMiddle AgedPneumoniaFibrinolytic AgentsTissue Plasminogen ActivatorExtracorporeal membrane oxygenation (ECMO)Low-resource settingsOxygenator thrombosisRecombinant tissue plasminogen activator (rtPA)Thrombolysis

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.